Method for preparing thermo-sensitive drug-release composite
A composite material and temperature-sensitive technology, which is applied in the direction of effective components of heterocyclic compounds and sheet-like transportation, can solve the problems of unavoidable use of organic solvents, complicated synthesis and preparation process, and uncontrollable drug loading, so as to improve the mechanical properties , good biocompatibility, overcome the effect that is difficult to control precisely
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0041] A polycaprolactone (matrix) / glycerol trilaurate (disperse phase) / sodium diclofenac (drug) temperature-sensitive drug release composite material includes the following components and their contents in parts by weight:
[0042] Component Parts by weight
[0043] Polycaprolactone (for biodegradable polymer matrix) 90
[0044] Glyceryl trilaurate (a dispersed phase of hydrophobic biodegradable small molecules) 10
[0045] Diclofenac sodium (as a drug) 5
[0046] Explanation: the weight of diclofenac sodium (being a medicine) is 5% of the total weight of the biodegradable polymer matrix and the dispersed phase.
[0047] The first step, at first prepare raw materials by above-mentioned components;
[0048] In the second step, the above materials were dried in a vacuum oven at 40°C for 12 hours;
[0049] In the third step, the dried polycaprolactone, glycerol trilaurate, and sodium diclofenac obtained in the second step are placed together in a high-mixer and pre-mixed for...
Embodiment 2
[0056] The raw materials of a polybutylene succinate (matrix) / glycerol tristearate (disperse phase) / metoprolol tartrate (drug) temperature-sensitive drug release composite material include the following components and parts by weight :
[0057] Component Parts by weight
[0058] Polybutylene succinate (for biodegradable polymer matrix) 80
[0059] Glycerol tristearate (a dispersed phase of hydrophobic biodegradable small molecules) 20
[0060] Metoprolol tartrate (as drug) 10
[0061] Explanation: the weight of metoprolol tartrate (being medicine) is 5% of the total weight of biodegradable polymer matrix and dispersed phase.
[0062] The first step, at first prepare raw materials by above-mentioned components;
[0063] In the second step, the polybutylene succinate and metoprolol tartrate were dried in a vacuum oven at 60°C for 12 hours, and glycerol tristearate was dried in a vacuum oven at 40°C for 12 hours;
[0064] In the third step, the dry polybutylene succinate, gl...
Embodiment 3
[0071] A raw material of ethyl cellulose (matrix) / tripalmitin-lauric acid (disperse phase) / cephalexin (drug) temperature-sensitive drug release composite material includes the following components and contents in parts by weight:
[0072] Component Parts by weight
[0073] Ethyl cellulose (for biodegradable polymer matrix) 80
[0074] Glyceryl tripalmitate (a hydrophobic biodegradable small molecule dispersed phase 1) 15
[0075] Lauric acid (as the dispersed phase of hydrophobic biodegradable small molecules 2) 5
[0076] Cephalexin (as a drug) 5
[0077] Explanation: the weight of cephalexin (being a medicine) is 5% of the total weight of the biodegradable polymer matrix and the dispersed phase.
[0078] The first step, at first prepare raw materials by above-mentioned components;
[0079] In the second step, the ethyl cellulose and cephalexin were dried in a vacuum oven at 60°C for 12 hours, and the tripalmitin and lauric acid were dried in a vacuum oven at 35°C for 12 ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Diameter | aaaaa | aaaaa |
| Thickness | aaaaa | aaaaa |
| Tensile yield strength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More